Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $5.1 million.

  • Healthcare Triangle's Total Liabilities fell 2235.72% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 2235.72%. This contributed to the annual value of $7.1 million for FY2024, which is 1423.2% down from last year.
  • As of Q3 2025, Healthcare Triangle's Total Liabilities stood at $5.1 million, which was down 2235.72% from $4.4 million recorded in Q2 2025.
  • Healthcare Triangle's Total Liabilities' 5-year high stood at $9.6 million during Q1 2023, with a 5-year trough of $3.2 million in Q1 2025.
  • For the 5-year period, Healthcare Triangle's Total Liabilities averaged around $7.2 million, with its median value being $7.4 million (2024).
  • As far as peak fluctuations go, Healthcare Triangle's Total Liabilities soared by 45414.38% in 2021, and later crashed by 5654.88% in 2025.
  • Healthcare Triangle's Total Liabilities (Quarter) stood at $8.5 million in 2021, then dropped by 14.81% to $7.2 million in 2022, then grew by 14.22% to $8.2 million in 2023, then decreased by 14.23% to $7.1 million in 2024, then decreased by 27.75% to $5.1 million in 2025.
  • Its Total Liabilities was $5.1 million in Q3 2025, compared to $4.4 million in Q2 2025 and $3.2 million in Q1 2025.